Source and scope
This summary is bounded to the recommendations, population and decisions covered by Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CSRS validation
Source-attributed clinical priorities
- Distinguish syncope from seizure, intoxication, metabolic disturbance and mechanical fall using witness history and recovery features.
- Perform cardiovascular examination and ECG, and identify high-risk features requiring monitored or urgent assessment.
- Use the Canadian Syncope Risk Score only in the validated emergency-department population and not as a substitute for clinical judgement.
- Use the Canadian Syncope Risk Score only after ED assessment identifies a patient matching its validation population.
sources for this section:CSRS validation
Practical assessment and management workflow
1
Obtain witness history, prodrome, posture, duration, movements, recovery and injury details.
2
Measure orthostatic vitals and obtain ECG, glucose and targeted testing based on the presentation.
3
Identify vasovagal, orthostatic, cardiac, seizure and other causes and disposition by risk.
4
Arrange rhythm or specialist follow-up for unexplained or recurrent events and give driving advice.
sources for this section:CSRS validation
Safety, red flags and urgent escalation
- Escalate exertional syncope, abnormal ECG, heart failure, family sudden death or persistent instability.
- Do not diagnose seizure from brief myoclonic movements alone during syncope.
- Apply provincial licensing and mandatory-reporting requirements to driving restrictions.
sources for this section:CSRS validation
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CSRS validation
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CSRS validation
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- JAMA Internal MedicineMulticenter Emergency Department Validation of the Canadian Syncope Risk ScoreDOI 10.1001/jamainternmed.2020.0288 路 JAMA Intern Med 2020;180(5):737-744 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.